Pirsidomine
Pirsidomine is a nitric oxide donor. Pirsidomine is a sydnonimine compound. Pirsidomine can transform into a nitric oxide-releasing metabolite in vivo. Pirsidomine prevents occlusion-induced increase in flow in the non-occluded circumflex coronary artery and significantly reduces the blood flow in non-ischemic areas in myocardial infarction dog model. Pirsidomine can be studied in research on cardiovascular diseases.
For research use only. We do not sell to patients.
- CAS No.: 132722-74-8
- Formula: C17H22N4O3
- Molecular Weight:330.38
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All Endogenous Metabolite Isoforms
More
Biological Activity
Chemical Information
-
CAS No. 132722-74-8
-
Molecular Weight 330.38
-
Formula C17H22N4O3
-
SMILES
C[C@H]1N([N+]2=NOC([N-]C(C3=CC=C(OC)C=C3)=O)=C2)[C@H](CCC1)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Martorana, P. A., et al., (1994). Antiischemic effects of pirsidomine, a new nitric oxide donor. European journal of pharmacology, 257(3), 267-273. [Content Brief]
[2]. Stengele, E., et al., (1996). Short-term hemodynamic, anti-ischemic, and antianginal effects of pirsidomine, a new sydnonimine. The American journal of cardiology, 77(11), 937-941. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pirsidomine Related Classifications
HY-105209 Related Classifications
Powered by Bioz